BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36108149)

  • 1. Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses.
    Gargiulo E; Viry E; Morande PE; Largeot A; Gonder S; Xian F; Ioannou N; Benzarti M; Kleine Borgmann FB; Mittelbronn M; Dittmar G; Nazarov PV; Meiser J; Stamatopoulos B; Ramsay AG; Moussay E; Paggetti J
    Blood Cancer Discov; 2023 Jan; 4(1):54-77. PubMed ID: 36108149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small extracellular vesicles: multi-faceted tools for leukemia immune evasion
    Gargiulo E; Viry E; Moussay E; Paggetti J
    Oncoimmunology; 2022; 11(1):2127507. PubMed ID: 36185808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive Extracellular Vesicles in CLL.
    Zhong W; Guo W
    Blood Cancer Discov; 2023 Jan; 4(1):5-7. PubMed ID: 36455131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Llaó Cid L; Hanna BS; Iskar M; Roessner PM; Öztürk S; Lichter P; Zapatka M; Seiffert M
    Leuk Lymphoma; 2020 Feb; 61(2):351-356. PubMed ID: 31519123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
    Peng M; Ren J; Jing Y; Jiang X; Xiao Q; Huang J; Tao Y; Lei L; Wang X; Yang Z; Yang Z; Zhan Q; Lin C; Jin G; Zhang X; Zhang L
    J Extracell Vesicles; 2021 Nov; 10(13):e12168. PubMed ID: 34807526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.
    Vlachonikola E; Stamatopoulos K; Chatzidimitriou A
    Front Immunol; 2020; 11():612244. PubMed ID: 33552073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.
    Pagano G; Botana IF; Wierz M; Roessner PM; Ioannou N; Zhou X; Al-Hity G; Borne C; Gargiulo E; Gonder S; Qu B; Stamatopoulos B; Ramsay AG; Seiffert M; Largeot A; Moussay E; Paggetti J
    Haematologica; 2023 Nov; 108(11):3011-3024. PubMed ID: 37345470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.
    Wu J; Xu X; Lee EJ; Shull AY; Pei L; Awan F; Wang X; Choi JH; Deng L; Xin HB; Zhong W; Liang J; Miao Y; Wu Y; Fan L; Li J; Xu W; Shi H
    Oncotarget; 2016 Jun; 7(26):40558-40570. PubMed ID: 27302925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
    Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J
    Front Immunol; 2020; 11():590072. PubMed ID: 33329575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded antigen-experienced CD160
    Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-derived small extracellular vesicles contribute to the tumour progression through reshaping the systemic immune macroenvironment.
    Du Z; Zhang H; Feng Y; Zhan D; Li S; Tu C; Liu J; Wang J
    Br J Cancer; 2023 Mar; 128(7):1249-1266. PubMed ID: 36755063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
    Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
    Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8
    Rezazadeh H; Astaneh M; Tehrani M; Hossein-Nataj H; Zaboli E; Shekarriz R; Asgarian-Omran H
    Immunol Res; 2020 Oct; 68(5):269-279. PubMed ID: 32710227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
    Sordo-Bahamonde C; Lorenzo-Herrero S; Martínez-Pérez A; Gonzalez-Rodriguez AP; Payer ÁR; González-García E; Aguilar-García C; González-Rodríguez S; López-Soto A; García-Torre A; Gonzalez S
    Cancer Immunol Immunother; 2023 Jul; 72(7):2529-2539. PubMed ID: 37041226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of chronic lymphocytic leukemia development by clonally-expanded CD8
    Hanna BS; Roessner PM; Yazdanparast H; Colomer D; Campo E; Kugler S; Yosifov D; Stilgenbauer S; Schmidt M; Gabriel R; Lichter P; Seiffert M
    Leukemia; 2019 Mar; 33(3):625-637. PubMed ID: 30267008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.
    Fedorchenko O; Stiefelhagen M; Peer-Zada AA; Barthel R; Mayer P; Eckei L; Breuer A; Crispatzu G; Rosen N; Landwehr T; Lilienthal N; Möllmann M; Montesinos-Rongen M; Heukamp L; Dürig J; Hallek M; Fingerle-Rowson G; Herling M
    Blood; 2013 May; 121(20):4126-36. PubMed ID: 23547049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
    Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
    Front Immunol; 2019; 10():2455. PubMed ID: 31681329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia.
    McClanahan F; Hanna B; Miller S; Clear AJ; Lichter P; Gribben JG; Seiffert M
    Blood; 2015 Jul; 126(2):203-11. PubMed ID: 25800048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 AND TIM-3 BLOCKING CANNOT ENHANCE APOPTOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY PERIPHERAL BLOOD CD8
    Jafarkhani S; Hossein-Nataj H; Eslami-Jouybari M; Ghoreishi M; Asgarian-Omran H
    Exp Oncol; 2022 Dec; 44(4):287-294. PubMed ID: 36811540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.